Catholic University President Peter Kilpatrick Shares Initiatives, Innovation, and Enrollment Growth with U.S. Bishops

Washington, DC, Nov. 14, 2025 (GLOBE NEWSWIRE) — Peter Kilpatrick, president of The Catholic University of America, gave an invited address to the bishops of the United States during their November 2025 plenary meeting in Baltimore, Md. The University is the only university founded by the U.S. bishops, in 1887, with the approval of Pope […]

AI IS RESHAPING THE COMMUNICATIONS INDUSTRY, BRINGING BOTH OPPORTUNITY AND TENSION TO THE CEO-COMMS LEADER RELATIONSHIP, HARRISX-RAGAN SURVEY FINDS

AI Now Performs More Than Half of Communications Work in Nearly One-In-Three Organizations CEOs Would Choose a Custom-Trained AI Tool Over a Professional Human Speechwriter The 5th Annual HarrisX-Ragan Survey of Communications Leaders reveals insights from 400 CEOs and communications leaders on how the field is evolving and responding to new challenges and opportunities driven

Catholic University President Peter Kilpatrick Shares Initiatives, Innovation, and Enrollment Growth with U.S. Bishops

Catholic University President Peter Kilpatrick Shares Initiatives, Innovation, and Enrollment Growth with U.S. Bishops Highlights include new artificial intelligence (AI) institute, increased enrollment, and new theology and nursing programs GlobeNewswire November 14, 2025 Washington, DC, Nov. 14, 2025 (GLOBE NEWSWIRE) — Peter Kilpatrick, president of The Catholic University of America, gave an invited address to

HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results

(NASDAQ:HCWB), MIRAMAR, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and diseases, today reported financial results and recent business highlights for its third quarter ended September

NN, Inc. Provides Mid-Quarter Business Update

(NASDAQ:NNBR), NN forecasts profitable sales growth and adjusted EBITDA growth in 2026 Company is underway with strategic processes aimed at unlocking shareholder value CHARLOTTE, N.C., Nov. 14, 2025 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, today provided a business update to give

XMax Inc. Reports Third Quarter 2025 Financial Results

(NASDAQ:NVFY), LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) — XMax Inc. (“Xmax” or the “Company”) (NASDAQ: XWIN), today announced its unaudited financial results for the three months ended September 30, 2025. Operating Results for the Three Months ended September 30, 2025 Net Sales grew by 273% to $9.76 million from $2.62 million in the same

NN, Inc. Provides Mid-Quarter Business Update

NN, Inc. Provides Mid-Quarter Business Update GlobeNewswire November 14, 2025 NN forecasts profitable sales growth and adjusted EBITDA growth in 2026 Company is underway with strategic processes aimed at unlocking shareholder value CHARLOTTE, N.C., Nov. 14, 2025 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components

XMax Inc. Reports Third Quarter 2025 Financial Results

XMax Inc. Reports Third Quarter 2025 Financial Results GlobeNewswire November 14, 2025 LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) — XMax Inc. (“Xmax” or the “Company”) (NASDAQ: XWIN), today announced its unaudited financial results for the three months ended September 30, 2025. Operating Results for the Three Months ended September 30, 2025 Net Sales grew

HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results

HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results GlobeNewswire November 14, 2025 MIRAMAR, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and diseases,

PRMB, PRMW Investors Have Opportunity to Lead Primo Brands Corporation Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Primo Water Corporation (NYSE: PRMW) between June 17, 2024 and November 8, 2024, both dates inclusive, and/or (ii) purchasers of common stock of Primo Brands Corporation (NYSE: PRMB) between November 11,

Scroll to Top